Bita Vazir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bita Vazir has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Morteza Zendehdel
Department of Basic Sciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
3 shared publications Farrokhreza Kabir
Science and Research Branch
2 shared publications- Kimia Mahdavi
Department of Basic Sciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
2 shared publications - Kowsar Saffar
Department of Veterinary Basic Sciences, SR.C., Islamic Azad University, Tehran, Iran
2 shared publications - Shahin Hassanpour
Department of Basic Veterinary Sciences, SR.C., Islamic Azad University, Tehran, Iran
2 shared publications Ahamd Asghari
Islamic Azad University
1 shared publication
Latest Publications
- 21 June 2025
- Published by Springer Nature in Veterinary Research Communications
- Vol. 49 (4) , 1-12
Effects of central injection of liver-expressed antimicrobial peptide-2 (LEAP2) on feed intake in broiler chickens: interactions with opioidergic and serotonergic systems
The liver-expressed antimicrobial peptide-2 (LEAP2) is recognized for its role in regulating meal consumption in mammals, but its function in avian species, especially broiler chickens, is not well understood. This study investigates the impact of central LEAP2 injection on food intake in broiler chickens, and explores its interactions with the opioidergic and serotonergic systems. Across eight trials, we examined the relationships between these systems and LEAP2 concerning meal intake in meat-type chickens. In Experiment 1, broilers received an intracerebroventricular (ICV) infusion of LEAP2 (0.75, 1.5, and 3 nmol) alongside a control solution. Subsequent experiments involved injecting birds with β-FNA (mu opioid receptor antagonist), LEAP2 (3 nmol), and β-FNA + LEAP2 (Experiment 2), with Experiments 3–8 following a similar design, substituting β-FNA with nor-BNI (kappa opioid receptor antagonist), NTI (delta opioid receptor antagonist), PCPA (serotonin synthesis inhibitor), fluoxetine (serotonin reuptake inhibitor), 8-OH-DPAT (5-HT1A receptor agonist), and SB242084 (5-HT2C receptor antagonist). Cumulative meal consumption was measured for 120 min post-infusion. Results indicated that LEAP2 injection (1.5 and 3 nmol) significantly reduced feed intake in broilers compared to the control treatment (P < 0.05). Co-infusion of β-FNA, PCPA, and SB242084 + LEAP2 attenuated LEAP2-induced hypophagia (P < 0.05), while co-infusion of fluoxetine + LEAP2 amplified LEAP2-induced hypophagia compared to the control treatment (P < 0.05). These findings suggest that LEAP2 induces hypophagic effects in broiler chickens, potentially mediated through the mu opioid and 5-HT2C receptors. Graphical abstract
- 21 June 2025
- Published by Springer Nature in Veterinary Research Communications
- Vol. 49 (4) , 1-12
Effects of central injection of liver-expressed antimicrobial peptide-2 (LEAP2) on feed intake in broiler chickens: interactions with opioidergic and serotonergic systems
The liver-expressed antimicrobial peptide-2 (LEAP2) is recognized for its role in regulating meal consumption in mammals, but its function in avian species, especially broiler chickens, is not well understood. This study investigates the impact of central LEAP2 injection on food intake in broiler chickens, and explores its interactions with the opioidergic and serotonergic systems. Across eight trials, we examined the relationships between these systems and LEAP2 concerning meal intake in meat-type chickens. In Experiment 1, broilers received an intracerebroventricular (ICV) infusion of LEAP2 (0.75, 1.5, and 3 nmol) alongside a control solution. Subsequent experiments involved injecting birds with β-FNA (mu opioid receptor antagonist), LEAP2 (3 nmol), and β-FNA + LEAP2 (Experiment 2), with Experiments 3–8 following a similar design, substituting β-FNA with nor-BNI (kappa opioid receptor antagonist), NTI (delta opioid receptor antagonist), PCPA (serotonin synthesis inhibitor), fluoxetine (serotonin reuptake inhibitor), 8-OH-DPAT (5-HT1A receptor agonist), and SB242084 (5-HT2C receptor antagonist). Cumulative meal consumption was measured for 120 min post-infusion. Results indicated that LEAP2 injection (1.5 and 3 nmol) significantly reduced feed intake in broilers compared to the control treatment (P < 0.05). Co-infusion of β-FNA, PCPA, and SB242084 + LEAP2 attenuated LEAP2-induced hypophagia (P < 0.05), while co-infusion of fluoxetine + LEAP2 amplified LEAP2-induced hypophagia compared to the control treatment (P < 0.05). These findings suggest that LEAP2 induces hypophagic effects in broiler chickens, potentially mediated through the mu opioid and 5-HT2C receptors. Graphical abstract
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
- Vol. 77 (4)
Effects of selective serotonin and norepinephrine reuptake inhibitor (Venlafaxine) in urine marking behavior in castrated male cats
To evaluate the effectiveness of a selective serotonin and norepinephrine reuptake inhibitor (SSNRI), Venlafaxine was used to alleviate problem urine marking in castrated male cats. Randomized placebo-controlled trial double-blind clinical trial. Twenty castrated male cats more than one-year-old objectionable reduction urine marking behavior. Owners recorded urine marking happening for two weeks. Cats that vertically marked a mean of ≥6 times per week were treated for two weeks by Venlafaxine or sterile water as placebo. Associated by decreasing the urine marking behavior if the urine marking decreased by 70 percent the treatment continued for 4 weeks and receiving was continued. The comparison of two groups showed that the second group that took drug had stronger significant correlation (P=0.001) despite the placebo controlled trial (P=0.021).
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
- Vol. 77 (4)
Open AccessEffects of selective serotonin and norepinephrine reuptake inhibitor (Venlafaxine) in urine marking behavior in castrated male cats
To evaluate the effectiveness of a selective serotonin and norepinephrine reuptake inhibitor (SSNRI), Venlafaxine was used to alleviate problem urine marking in castrated male cats. Randomized placebo-controlled trial double-blind clinical trial. Twenty castrated male cats more than one-year-old objectionable reduction urine marking behavior. Owners recorded urine marking happening for two weeks. Cats that vertically marked a mean of ≥6 times per week were treated for two weeks by Venlafaxine or sterile water as placebo. Associated by decreasing the urine marking behavior if the urine marking decreased by 70 percent the treatment continued for 4 weeks and receiving was continued. The comparison of two groups showed that the second group that took drug had stronger significant correlation (P=0.001) despite the placebo controlled trial (P=0.021).
- 1 January 2023
- Published by Diva Enterprises Private Limited in Journal of Immunology and Immunopathology
- Vol. 25 (2) , 127-133
Behavioral Dynamics in Neutered Dogs: Unraveling the Role of Various Factors
Studies examining the potential effects of neutering on pet behavior aim to provide a comprehensive understanding of the subject, encompassing various aspects of pet behavior and the impact of neutering. Extensive research conducted in this field underscores the significance of the topic among researchers. This study specifically explores the relationship between influential factors and the effects of neutering on both individual and social behaviors in dogs. To gather information, a questionnaire was prepared and distributed, drawing data from reliable national and international scientific databases. Utilizing Cochran’s statistical relationship, 192 questionnaires related to pets were completed and subsequently analyzed using SPSS-24 software. The statistical findings shed light on the following results: “The factors of neutering time, sexual cycle, and the dog’s living environment play a role in the occurrence of different behaviors. However, age, weight, and the presence of other pets do not affect these behaviors. The investigati on into the effects of neutering on dogs revealed significant differences in behavior before and after the procedure. This study offers valuable insights for the scientific community and dog guardians, demonstrating that neutering has a significant impact on reducing unwanted behaviors and facilitating practical management while promoting responsible pet ownership”.
- 1 January 2023
- Published by Diva Enterprises Private Limited in Journal of Immunology and Immunopathology
- Vol. 25 (2) , 127-133
Behavioral Dynamics in Neutered Dogs: Unraveling the Role of Various Factors
Studies examining the potential effects of neutering on pet behavior aim to provide a comprehensive understanding of the subject, encompassing various aspects of pet behavior and the impact of neutering. Extensive research conducted in this field underscores the significance of the topic among researchers. This study specifically explores the relationship between influential factors and the effects of neutering on both individual and social behaviors in dogs. To gather information, a questionnaire was prepared and distributed, drawing data from reliable national and international scientific databases. Utilizing Cochran’s statistical relationship, 192 questionnaires related to pets were completed and subsequently analyzed using SPSS-24 software. The statistical findings shed light on the following results: “The factors of neutering time, sexual cycle, and the dog’s living environment play a role in the occurrence of different behaviors. However, age, weight, and the presence of other pets do not affect these behaviors. The investigati on into the effects of neutering on dogs revealed significant differences in behavior before and after the procedure. This study offers valuable insights for the scientific community and dog guardians, demonstrating that neutering has a significant impact on reducing unwanted behaviors and facilitating practical management while promoting responsible pet ownership”.
- 9 June 2022
- Published by Springer Nature in Comparative Clinical Pathology
- Vol. 31 (4) , 579-584
Mucocutaneous Bowen’s disease with a cutaneous horn overgrowth in a German shepherd dog
- 9 June 2022
- Published by Springer Nature in Comparative Clinical Pathology
- Vol. 31 (4) , 579-584
Mucocutaneous Bowen’s disease with a cutaneous horn overgrowth in a German shepherd dog
- 16 March 2019
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 26 (1) , 1-10
Central Opioidergic and Adrenergic systems Mediates Food Intake via α1, α2 and β2 Receptors in Neonatal Layer-Type Chicken
- 16 March 2019
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 26 (1) , 1-10
Central Opioidergic and Adrenergic systems Mediates Food Intake via α1, α2 and β2 Receptors in Neonatal Layer-Type Chicken